22 May 2013
Keywords: glaxosmithkline, warned, over, avandia, promotion, fda, been
Article | 06 August 2001
GlaxoSmithKline has been sent a warning letter from the US Food and DrugAdminstration charging that the company's sales representatives were
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 2001
7 August 2001
© 2013 thepharmaletter.com